U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07722000) titled 'Different Treatment Options Used for Post Covid-19 Syndrome' on July 19.
Brief Summary: This study aimed to assess functioning during the recovery phase post-COVID-19 and to evaluate symptoms prolonging after COVID-19 infection and how to manage these symptoms.
Study Start Date: Feb. 01, 2021
Study Type: INTERVENTIONAL
Condition:
COVID-19
Post COVID-19 Syndrome
Ginkgo Biloba
Piracetam
Intervention:
DRUG: Ginkgo biloba
Patients who received Ginkgo biloba alone.
DRUG: Piracetam
Patients who received piracetam alone.
DRUG: Ginkgo biloba and Piracetam
Patients who received a combination (Ginkgo biloba and Piracetam).
Recruit...